This is not the first time PPAR activators have been shown to negatively influence pancreatic cancer cell invasion, and perhaps further in vivo studies using these mouse transplantable cell lines could provide more useful insight into the potential therapeutic uses of PPARβ/δ activators in the control and regulation of pancreatic cancer. This evidence concerns the gene PPARD and familial pancreatic carcinoma.